In chronic lymphocytic leukemia (CLL), the B cell receptor (BCR) plays a critical role in disease development and progression, as indicated by the therapeutic efficacy of drugs blocking BCR signaling. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.